Skip to main content
Clinical Trials/JPRN-UMIN000048852
JPRN-UMIN000048852RecruitingUnknown

Development of a biomarker of fibromyalgia on neuroinflammation. - Development of a biomarker of fibromyalgia on neuroinflammation.

Department of Psychosomatic Medicine, Graduate School of Medical Sciences, Kyushu University0 sites80 target enrollmentStarted: September 12, 2022Last updated:

Trial Snapshot

Phase
Unknown
Status
Recruiting
Sponsor
Enrollment
80

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • [Fibromyalgia] (1) Patients with symptoms of anemia (hemoglobin 8 g/dl or less) (2) Patients with poor general condition (PS value >3) (3) Patients diagnosed with autoimmune disease, chronic infectious disease, demyelinating disease, complement-related disease (PNH, NMO, MS), malignant disease (4) Other patients deemed by the investigator to be inappropriate as research subjects. [Chronic pain] (1) Patients with symptoms of anemia (hemoglobin of 8 g/dl or less) (2) Patients with poor general condition (numerical value: PS value 3 or higher) (3) Those diagnosed with autoimmune disease, chronic infectious disease, demyelinating disease, complement-related disease (PNH, NMO, MS), or malignant disease (4) Other subjects deemed by the investigator to be inappropriate as research subjects. [Healthy control] (1) Those with symptoms of anemia (hemoglobin 8 g/dl or less) (2) Patients with poor general condition (PS value of 3 or higher) (3) Patients receiving treatment for pain (4) Those diagnosed with autoimmune disease, chronic infectious disease, demyelinating disease, complement-related disease (PNH, NMO, MS), or malignant disease (5) Any other person whom the investigator deems inappropriate as a research subject.

Investigators

Sponsor
Department of Psychosomatic Medicine, Graduate School of Medical Sciences, Kyushu University

Similar Trials